What is MLAB's health score?

MESA LABORATORIES INC /CO/ (MLAB) has a TradeApes health score of 42 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MLAB's estimated fair value?

Based on our 5-year discounted cash flow model, MESA LABORATORIES INC /CO/'s estimated fair value is $32.26 per share, representing a -69.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MLAB undervalued or overvalued?

Our model currently rates MLAB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MLAB... Refresh in a moment for the full analysis.

MESA LABORATORIES INC /CO/ (MLAB)

Healthcare Overvalued low weak

$104.38

Updated: 2026-06-04

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

38 Weak

Relative Value

35 Weak

Capital Allocation

35 Weak

Risk

70 Healthy

Est. Fair Value $32.26

DCF Upside -69.1%

Sector Rank #624 of 6863

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.